PFX:NASDAQPhenixFIN Corporation Analysis

PhenixFIN (PFX) is trading at $45.49, just shy of its $45.5 resistance level and above its 20‑day SMA of 42.27, while the 14‑day RSI sits at 65, hinting at near‑overbought conditions. The MACD remains bullish (line above signal) but volume is on a decreasing trend, and a 30‑day volatility of over 40% underscores a choppy price environment. Despite a forward P/E of 23 × versus an industry average of 17 ×, the stock’s price‑to‑book is only 0.57, suggesting a relatively cheap valuation on a balance‑sheet basis.
Fundamentally, the company faces headwinds: revenue fell 13.6% year‑over‑year, profit margin is negative, and trailing EPS is –$0.55, though forward EPS is projected at $1.97. The balance sheet is strained with $149 M of debt (debt‑to‑equity ~97) and negative operating cash flow, while recent Q2 results showed a modest $1.1 M net income and the CEO’s 20% share purchase adds a modest confidence boost.